Yi-Yun Cheng

Title: Yi-Yun Cheng: Innovator in COVID-19 Treatment

Introduction

Yi-Yun Cheng is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical science, particularly in the fight against COVID-19. His innovative approach has led to the development of a unique method for treating SARS-CoV2 related diseases.

Latest Patents

Yi-Yun Cheng holds a patent for a method and combination for the suppression of the COVID-19 virus. This patent outlines a method for treating a SARS-CoV2 3CL-related disease by blocking the dimerization of the 3C-like main protease (3CL) of the SARS-CoV2 virus. The method involves administering a first agent that binds to a first binding site of the SARS-CoV2 3CL complex and a second agent that binds to a second binding site, which are functionally different sites in the three-dimensional structure of the complex. This pharmaceutical combination aims to suppress SARS-CoV2, thereby alleviating COVID-19.

Career Highlights

Throughout his career, Yi-Yun Cheng has worked with esteemed institutions such as Tsinghua University and Praexisio Taiwan, Inc. His work has been pivotal in advancing research and development in the medical field, particularly in virology and therapeutic methods.

Collaborations

Yi-Yun Cheng has collaborated with notable colleagues, including Lee-Wei Yang and Kun-Lin Tsai. These partnerships have contributed to the success of his research and innovations.

Conclusion

Yi-Yun Cheng's contributions to the treatment of COVID-19 through his innovative patent demonstrate his commitment to advancing medical science. His work not only showcases his expertise but also highlights the importance of collaboration in achieving significant breakthroughs in healthcare.